- Stock Analysis
- Analyst Forecasts
- Chart
- Competitors
- Earnings
- Financials
- Headlines
- Insider Trades
- Options Chain
- Ownership
- SEC Filings
- Short Interest
- Trends
Black Diamond Therapeutics Latest Earnings Summary
- Upcoming
Earnings Date - Mar. 11Estimated
- Actual EPS
(Nov. 5) - -$0.28 Beat By $0.09
- Consensus EPS
(Nov. 5) - -$0.37
Black Diamond Therapeutics released Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.28, which topped the consensus estimate of -$0.37 by $0.09. With a trailing EPS of -$1.33, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share.
BDTX Upcoming Earnings
Black Diamond Therapeutics' next earnings date is estimated for Tuesday, March 11, 2025, based off prior year's reporting schedules.
Get Black Diamond Therapeutics Earnings Alerts
Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox.
BDTX Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
BDTX Estimated and Actual Revenue by Quarter
The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Black Diamond Therapeutics Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.44 | -$0.41 | -$0.43 |
| Q2 2024 | 2 | -$0.39 | -$0.35 | -$0.37 |
| Q3 2024 | 2 | -$0.40 | -$0.37 | -$0.39 |
| Q4 2024 | 2 | -$0.31 | -$0.29 | -$0.30 |
| FY 2024 | 8 | -$1.54 | -$1.42 | -$1.48 |
| Q1 2025 | 2 | -$0.31 | -$0.21 | -$0.26 |
| Q2 2025 | 2 | -$0.32 | -$0.22 | -$0.27 |
| Q3 2025 | 2 | -$0.32 | -$0.22 | -$0.27 |
| Q4 2025 | 2 | -$0.33 | -$0.18 | -$0.26 |
| FY 2025 | 8 | ($1.28) | ($0.83) | ($1.06) |
Black Diamond Therapeutics Earnings History by Quarter
Export to Excel
Black Diamond Therapeutics Earnings - Frequently Asked Questions
Black Diamond Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 11th, 2025 based off last year's report dates. Learn more on BDTX's earnings history.
In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.09. Learn more on analysts' earnings estimate vs. BDTX's actual earnings.
Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$82.44 million. BDTX has generated -$1.33 earnings per share over the last four quarters.
Black Diamond Therapeutics's earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year.
`
More Earnings Resources from MarketBeat
Related Companies
- Compugen Earnings Results
- Inhibrx Earnings Results
- iTeos Therapeutics Earnings Results
- C4 Therapeutics Earnings Results
- Nuvation Bio Earnings Results
- ORIC Pharmaceuticals Earnings Results
- Stoke Therapeutics Earnings Results
- CorMedix Earnings Results
- Exscientia Earnings Results
- Tectonic Therapeutic Earnings Results
Earnings Tools
- Today's Earnings
- Tomorrow's Earnings
- Next Week's Earnings
- Upcoming Earnings Calls
- Earnings Newsletter
- Earnings Call Transcripts
- Corporate Guidance
- Earnings Screener
Earnings By Country
- U.S. Earnings Reports
- Canadian Earnings Reports
- U.K. Earnings Reports
Latest Articles
- Alibaba Stock: Why Earnings Make It a Buy Despite the Recent Dip
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?
- Apple Earnings - When Really Good Just Isn’t Good Enough
- Roblox Stock Set for More Gains After Strong Earnings Report
- Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
This page (NASDAQ:BDTX) was last updated on 11/19/2024 by MarketBeat.com Staff
From Our Partners
